Rituximab decreases the risk of lymphoma in patients with HTV-associated multicentric Castleman disease.
Saved in:
| Title: | Rituximab decreases the risk of lymphoma in patients with HTV-associated multicentric Castleman disease. |
|---|---|
| Authors: | Gérard, Laurence1 laurence.gerard@sls.aphp.fr, Michot, Jean-Marie1, Burcheri, Sara1, Fieschi, Claire1, Longuet, Pacale2, Delcey, Véronique3, Meignin, Véronique4, Agbalika, Felix5, Chevret, Sylvie6, Oksenhendler, Eric1, Galicier, Lionel1 |
| Source: | Blood. 3/8/2012, Vol. 119 Issue 10, p2228-2233. 6p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00064971 |
|---|---|
| DOI: | 10.1182/blood-2011-08-376012 |
